TipRanks
Advertisement
Advertisement
Otsuka’s Zipalertinib Combo Hits Phase 3 Goal in Targeted Lung Cancer Trial
PremiumCompany AnnouncementsOtsuka’s Zipalertinib Combo Hits Phase 3 Goal in Targeted Lung Cancer Trial
2M ago
Otsuka’s VOYXACT Phase 3 Data Show Sustained Kidney Function Stabilization in IgA Nephropathy
Premium
Company Announcements
Otsuka’s VOYXACT Phase 3 Data Show Sustained Kidney Function Stabilization in IgA Nephropathy
2M ago
Otsuka Holdings Continues Share Buybacks Under ¥50 Billion Authorization
Premium
Company Announcements
Otsuka Holdings Continues Share Buybacks Under ¥50 Billion Authorization
2M ago
Otsuka’s VOYXACT Achieves Key Phase 3 Success in IgA Nephropathy, Bolstering Long-Term Growth Strategy
PremiumCompany AnnouncementsOtsuka’s VOYXACT Achieves Key Phase 3 Success in IgA Nephropathy, Bolstering Long-Term Growth Strategy
3M ago
Otsuka Holdings Advances Share Buyback, Repurchases ¥29.9 Billion in Stock
Premium
Company Announcements
Otsuka Holdings Advances Share Buyback, Repurchases ¥29.9 Billion in Stock
3M ago
Otsuka’s VOYXACT Shows Kidney Function Preservation in Phase 3 IgA Nephropathy Trial
Premium
Company Announcements
Otsuka’s VOYXACT Shows Kidney Function Preservation in Phase 3 IgA Nephropathy Trial
4M ago
Otsuka Holdings Co  (OTSKF) Q1 Earnings Cheat Sheet
PremiumPre-EarningsOtsuka Holdings Co (OTSKF) Q1 Earnings Cheat Sheet
5M ago
Otsuka Completes Treasury Share Disposal for Restricted Stock Compensation
Premium
Company Announcements
Otsuka Completes Treasury Share Disposal for Restricted Stock Compensation
5M ago
Otsuka Advances ¥50 Billion Share Buyback Program on Tokyo Market
Premium
Company Announcements
Otsuka Advances ¥50 Billion Share Buyback Program on Tokyo Market
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―